Technetium Tc 99M Tilmanocept
Protein
Overview
Technetium Tc 99M Tilmanocept is a protein active pharmaceutical ingredient (ChEMBL CHEMBL2108726).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Technetium Tc 99M Tilmanocept expires 30 Jan 2029. Generic API sourcing typically opens up once these lapse.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.